how-to
How to Understand Spravato for Depression
Last Updated: November 1, 2026
Quick Summary
Spravato for depression works by targeting glutamate, the brain's main excitatory neurotransmitter, rather than serotonin or norepinephrine. Esketamine blocks the NMDA receptor, which briefly shifts glutamate signaling and may help brain circuits reconnect. It is given as a supervised nasal spray and may act faster than standard oral antidepressants for some people.
- Esketamine is a nasal spray given in a monitored clinical setting, never taken home.
- Some people notice mood changes within hours to days, while others need several sessions.
- Each visit includes a monitored observation period of about two hours with blood pressure checks.
- You cannot drive yourself home after a session and should not drive until your clinician clears you.
- Spravato is approved for treatment-resistant depression and is used alongside an oral antidepressant.
Table of Contents
- How Spravato Works for Depression: Glutamate and NMDA Receptors
- How Quickly Does Spravato Work?
- What to Expect During Spravato Treatment
- Spravato Side Effects and Safety Monitoring
- Spravato Treatment Schedule: Induction and Maintenance
- Who May Qualify for Spravato and How It Compares to Other Options
- Starting Spravato Treatment with Trust and Care Mental Health Inc
- Frequently Asked Questions
How Spravato Works for Depression: Glutamate and NMDA Receptors
Spravato for depression works differently than many oral antidepressants. Most antidepressants target serotonin or norepinephrine. Spravato targets glutamate, the brain's main excitatory neurotransmitter, and it is generally described as acting faster than standard oral antidepressants for some people.
At Trust and Care Mental Health Inc, we are happy to explain this to patients who have already tried two or more antidepressants without relief. The question "how does spravato work for depression" deserves a clear answer, not jargon.
Here is the short version: esketamine is a nasal spray given under supervision. It briefly changes how glutamate signals travel between brain regions involved in mood regulation. That change may help brain circuits reconnect.
Below, we walk through the science, the uncertainties, and what a real treatment visit looks like.
What Esketamine Is and How It Differs from Other Antidepressants
Esketamine is a version of ketamine refined for nasal use and approved as a prescription treatment for depression. It is not a take-home drug. A clinician gives it in a monitored setting.
Standard antidepressants usually raise serotonin or norepinephrine levels over weeks. Esketamine instead acts on the glutamate system. That is why it is often called a rapid-acting treatment.
The Proposed Mechanism and What Remains Uncertain
The leading theory centers on the NMDA receptor. Esketamine blocks this receptor, which briefly shifts glutamate signaling. Researchers believe this may trigger new synaptic connections, a process tied to neuroplasticity.
Scientists do not fully understand why this produces symptom reduction in some people and not others, and response varies from person to person.
What most guides miss: the mechanism is a working model, not a settled fact. The National Institute of Mental Health overview of depression notes that depression itself involves complex brain signaling we are still mapping.
How Quickly Does Spravato Work?
Some people notice a change in mood within hours to days. Others need several sessions before any shift appears, and the timeline varies from person to person.
Esketamine may act faster for some patients than standard oral antidepressants, which often take weeks to show benefit.
But faster does not mean instant or guaranteed. A single dose is not a cure. Improvement usually builds across the induction phase, and your prescriber tracks progress with a depression rating scale called the MADRS.
What to Expect During Spravato Treatment
A Spravato visit is a scheduled clinical appointment that includes a supervised observation period after each dose. Ask your care team how long your appointments will take.
A Step-by-Step Account of a Treatment Visit
Treatment centers generally follow a supervised sequence that includes observation after each dose. Exact steps vary by clinic, so ask your care team what to expect.
- Check-in and symptom review. Staff confirm your identity, ask about changes since your last visit, and review any medications or side effects you noticed. Bring your oral antidepressant schedule and any questions.
- Baseline measurements. Your blood pressure is checked before dosing. If it is elevated above the clinic's threshold, the dose may be delayed or rescheduled, this is a safety step, not a judgment.
- Self-administration under supervision. You spray the dose into one nostril while a clinician observes. You do not take the device home. The clinician confirms the dose was delivered correctly.
- Monitored observation period. You rest in a reclining chair for about two hours. Staff check blood pressure periodically and watch for dissociation, sedation, and blood pressure changes. Most clinics dim the lights and keep the room quiet.
- Final check and discharge review. A last blood pressure reading and a conversation about how you feel determine whether you are cleared to leave. You will be told not to drive and given instructions for the rest of the day.
- Ride home. Arrange for a friend, family member, or ride service in advance. Do not plan to drive yourself.
What to Bring and How to Prepare
Bring a photo ID, your insurance card, a list of current medications, and the name of the person picking you up. Ask your prescriber about eating, drinking, and alcohol before and after the session. Wear comfortable clothing.
Plan ahead for the time commitment that supervised visits involve.
Spravato Side Effects and Safety Monitoring
Spravato side effects are generally short-lived and are one reason the medication is given under supervision rather than at home. The most commonly reported effects are dissociation, sedation, dizziness, nausea, and temporary increases in blood pressure. Knowing what is expected, and what is not, helps you speak up early. For practical guidance on managing side effects during esketamine therapy, see our dedicated article.
Common Side Effects and What They Feel Like
- Dissociation. A sense of detachment from your body, thoughts, or surroundings. It can feel strange but usually fades within the observation period. Tell your clinician how intense it feels so they can adjust monitoring.
- Sedation. Drowsiness or a heavy, relaxed feeling. This is why you cannot drive after a dose.
- Blood pressure changes. Spravato can raise blood pressure for a short time. Blood pressure is typically checked before dosing and during observation, and a dose may be delayed if a reading is too high.
- Dizziness and nausea. Usually mild and manageable in a reclined position. Report them so staff can help.
Driving Restrictions and Post-Dose Monitoring
You cannot drive yourself home after a session, and you should not drive until your clinician clears you, typically the next day, depending on how you feel. Sedation and dissociation can linger, and driving before you are cleared is unsafe. Plan for a ride in advance and avoid operating machinery or making important decisions for the rest of the day.
Monitoring during supervised visits generally includes blood pressure checks and observation, and your care team decides when you are ready to leave. Our patient guide to Spravato monitoring explains what to expect in more detail.
When to Call Your Care Team
Contact your prescriber if you notice side effects that persist beyond the visit, blood pressure readings at home that stay elevated, mood changes that worry you, or any return of suicidal thoughts. Spravato is used alongside an oral antidepressant, and your care team needs to know how both are affecting you between visits.
Spravato Treatment Schedule: Induction and Maintenance
Treatment is generally described in two phases, an induction phase with more frequent sessions and a maintenance phase with sessions spaced further apart. Your prescriber sets the exact schedule.
Your prescriber sets the exact schedule based on how you respond. Dose and frequency are adjusted to your needs and side effects.
The schedule is a commitment, and it is fair to ask about time. A common mistake is underestimating the two-hour monitoring window when planning work or family logistics.
Who May Qualify for Spravato and How It Compares to Other Options
Spravato is approved for treatment-resistant depression, and it is used alongside an oral antidepressant. Eligibility is determined by a prescriber.
Eligibility depends on your history, current symptoms, and a prescriber's review. Suicidal risk and other factors shape the decision.
Compared with other options, esketamine may have a faster onset for some people but requires supervised visits. Standard antidepressants are taken at home. Therapy and other medications are also options to discuss with a clinician.
| Option | How It's Given | Typical Onset | Supervision Needed |
|---|---|---|---|
| Spravato (esketamine) | Nasal spray in clinic | Hours to days for some | Yes, about 2 hours |
| Standard oral antidepressant | Daily pill at home | Several weeks | No |
| Therapy alone | Talk sessions | Varies by person | No |
Starting Spravato Treatment with Trust and Care Mental Health Inc
Deciding to try Spravato takes courage, especially after failed attempts. Trust and Care Mental Health Inc offers a monitored clinical setting, and our team can discuss your options with you.
Trust and Care Mental Health Inc offers administration of FDA-approved Spravato nasal spray and treatment-only options for referring providers, and serves children, adults, and older adults.
If cost is on your mind, please contact Trust and Care Mental Health Inc directly or check your insurance plan for current coverage details.
Frequently Asked Questions
How does Spravato work for depression?
Spravato (esketamine) is a nasal spray thought to act on the glutamate system, the brain's main excitatory neurotransmitter network. Rather than targeting serotonin alone like many standard antidepressants, it blocks NMDA receptors and is believed to influence glutamate signaling and synaptic connections involved in mood regulation. Researchers propose this may support neuroplasticity and improve communication between brain regions. The exact mechanism is still being studied, and response varies from person to person. It is approved for treatment-resistant depression and used alongside an oral antidepressant.
How quickly does Spravato start working?
Some patients notice symptom reduction within hours to days, which is why esketamine is described as a rapid-acting treatment. That said, onset of effect varies widely. Some people respond after the first few sessions, others need several weeks of the induction phase. If there is no meaningful response after a reasonable trial, your prescriber may reassess the plan. Ask your clinician what timeline to expect for your situation.
What are the most common Spravato side effects?
Common Spravato side effects include dissociation (a detached feeling), sedation, dizziness, nausea, and temporary increases in blood pressure. These usually occur shortly after dosing and ease within a couple of hours. Because of dissociation and blood pressure changes, Spravato is given under supervised administration with post-dose monitoring. It is not taken at home. Tell your prescriber about any heart or blood pressure conditions beforehand.
How is Spravato different from ketamine?
Spravato is esketamine, a component of ketamine, delivered as an FDA-approved nasal spray specifically for treatment-resistant depression. It requires supervised administration, post-dose monitoring, and is used alongside an oral antidepressant. Generic ketamine is not FDA-approved for depression and is often given intravenously in off-label settings. Spravato's approval comes with a structured safety program and a defined treatment schedule. The two share a similar glutamate-related mechanism, but the dosing, monitoring requirements, and clinical evidence base differ. Discuss both options with a qualified prescriber.
Depression that has resisted treatment is exhausting, and you deserve a clear path forward. At Trust and Care Mental Health Inc, we offer supervised Spravato administration, personalized medication management, and a safe clinical environment built around your safety. Get started with Trust and Care Mental Health Inc and take the next step toward steadier, better-supported mood care.
